Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
9.74
+0.69 (7.62%)
At close: May 12, 2025, 4:00 PM
10.23
+0.49 (5.03%)
After-hours: May 12, 2025, 4:38 PM EDT
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $407.46 million as of May 12, 2025.
Market Cap
407.46M
Enterprise Value
57.70M
1-Year Change
n/a
Ranking
Category
Stock Price
9.74
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has decreased from $676.47M to $407.46M, a decrease of -39.77%. That is a compound annual growth rate of -54.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 378.60M | 10.61% |
| Dec 31, 2024 | 342.27M | -49.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |